标普和纳斯达克内在价值 联系我们

ProPhase Labs, Inc. PRPH NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
34/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.00
+9214.7%

ProPhase Labs, Inc. (PRPH) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Garden City, NY, 美国. 现任CEO为 Ted William Karkus.

PRPH 拥有 IPO日期为 1994-04-04, 96 名全职员工, 在 NASDAQ Capital Marke, 市值为 $711.97K.

关于 ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

📍 711 Stewart Avenue, Garden City, NY 11530 📞 215 345 0919
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期1994-04-04
首席执行官Ted William Karkus
员工数96
交易信息
当前价格$0.15
市值$711.97K
52周区间0.07-6.7
Beta-0.52
ETF
ADR
CUSIP74345W108
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言